Global Ablation Devices Market Overview
The Ablation Devices Market Size was valued at USD 8.2 Billion in 2022 and is projected to grow from USD 9.0 Billion in 2023 to USD 18.6 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 9.50% during the forecast period (2023 - 2032). Due to the rising incidence of thyroid cancer and thyroid nodules as well as the tendency for minimally invasive treatments, there is an increasing need for thyroid ablation methods as well as equipment are the key market drivers enhancing the market growth.
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Ablation Devices Market Trends
- Increasing demand for thyroid ablation procedures as well as devices is driving the market growth
Due to the rising incidence of thyroid cancer and thyroid nodules, there is a rising demand for both thyroid ablation treatments and devices. The International Agency for Research on Cancer estimates that there were around 586,202 new thyroid cancer cases worldwide in 2020. Additionally, the availability of technologically advanced ablation methods and the growing inclination for less invasive surgeries are anticipated to fuel market expansion. The most popular and effective methods for treating thyroid cancer and nodules are these ones. Procedures for thyroid ablation are effective because they are less intrusive, potentially carry fewer risks, preserve more thyroid tissue, and aid patients in maintaining normal thyroid function. Radiation exposure is known to raise the risk of developing thyroid cancer. The International Agency for Research on Cancer (IARC) has discovered that having thyroid cancer increases your risk of being overweight or obese.
Follicular thyroid carcinoma is more common in areas with poor iodine consumption. Nevertheless, iodine-rich diets may raise the risk of papillary thyroid cancer. In America, most individuals get adequate iodine since it is added to table salt and other foods. The global industry has suffered as a result of the COVID-19 epidemic. Due to the fact that the planned thyroid ablation and thyroid cancer procedures were elective or non-essential, they were postponed by approximately 4 weeks when the infection started to spread. In the United States, sudden cardiac arrest is the primary cause of mortality, accounting for over 300,000 fatalities annually. According to a study by St. Jude Medical, Inc., there were approximately 250,000 catheter ablations conducted in the United States alone in 2015, compared to an estimated 990,000 worldwide. Catheter ablation is a technique used in electrophysiology to remove aberrant heart tissue that is the root of cardiac arrhythmia. The most popular ablation catheters today are radiofrequency and cryoablation, and more are anticipated in the future. Additionally, future projections indicate a sharp rise in the use of ablation techniques for the treatment of atrial fibrillation.
One of the main causes of illness and mortality worldwide is cancer. There were over 14.2 million new cases of cancer and 8.2 million cancer-related deaths in 2012. Within the next two decades, the WHO predicts a 70% increase in the number of new cases. Therefore, there is a pressing need for new, cutting-edge methods to cure cancer. Ablation is a method that employs heat to shrink the size of cancer cells and alleviate symptoms. It can be used alone or in conjunction with radiotherapy, chemotherapy, or surgery. Due to the very targeted nature of this treatment, which solely targets tumor tissues, there has been an upsurge in the demand for ablation system in recent years. Thus, driving the ablation system market revenue.
Ablation Devices Market Segment Insights
Ablation Devices Technology Insights
The Market segments of Ablation Devices, based on technology, includes thermal ablation and non-thermal ablation. Thermal ablation segment dominated the global market in 2022. Throughout the predicted period, the segment will remain in its current position. The effectiveness and safety of Thermal Ablation (TA) as an alternative to surgery for benign thyroid nodules (BTNs) are well documented.
Ablation Devices Application Insights
The Ablation Devices Market segmentation, based on application, includes cancer, cardiovascular, ophthalmology, gynecology, urology, orthopedics, and others. Cancer segment dominated the global market in 2022. The high percentage can be ascribed to the rising incidence of thyroid cancer worldwide. For instance, the International Agency for Research on Cancer projects that in 2025 there would be 1,984,927 instances of thyroid cancer. According to the same source, thyroid cancer would rank as the sixth most prevalent cancer in women in 2020.
Ablation Devices Function Insights
The market segmentation of ablation treatment devices, based on function, includes automated/robotic and conventional. Automated/robotic segment dominated the Ablation Devices Market in 2022. For tiny tumors, radiofrequency ablation is one of the most popular ablation techniques. High-energy radio waves are used. Without the need for traditional surgery, special probes are utilized to "burn" or "freeze" tumors. The needle probe is guided and positioned into the tumor using magnetic resonance imaging (MRI), ultrasound, or computed tomography (CT).
Figure 1: Ablation Devices Market, by Function, 2022 & 2032 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Ablation Devices Procedure Insights
The Market segmentation of Ablation Devices, based on Procedure, includes aesthetics-skin rejuvenation and tightening, aesthetics-body sculpting, fat reduction, and the reduction in the appearance of cellulite, benign prostatic hyperplasia, transurethral needle ablation, laser and other energy-based therapies/holmium laser ablation/enucleation of the prostate, stress urinary incontinence, menorrhagia/endometrial ablation, uterine fibroids, spinal decompression and denervation, varicose veins, atrial fibrillation, tumor ablation, and others. Aesthetics-skin rejuvenation and tightening segment dominated the market of ablation system 2022. This is related to the rise in demand for cosmetic procedures.
Ablation Devices Regional Insights
By region, the study provides the market insights into North America, Europe, Asia-Pacific and Rest of the World. The North America Ablation System Market dominated this market in 2022 (45.80%). The prevalence of thyroid cancer is rising, there are important participants in the market, and consumers have high purchasing power, all of which are significant drivers in the growth of the regional market. Further, the U.S. market of ablation system held the largest market share, and the Canada market of Ablation Devices was the fastest growing market in the North America region.
Further, the major countries studied in the market report are The US, Canada, German, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.
Europe ablation treatment devices market accounted for the healthy market share in 2022. This is brought on by the availability of promising ablation technologies, rising demand for less invasive medical procedures, and rising disposable incomes. Further, the German market of Ablation Devices held the largest market share, and the U.K market of ablation treatment devices was the fastest growing market in the European region
The Asia Pacific Ablation Devices market is expected to register significant growth from 2023 to 2032. The region's expanding patient base and growing demand for improved care are likely contributing factors to the rapid rise. Additionally, with government assistance, healthcare use is expanding throughout Asia and the Pacific. Moreover, China’s market of ablation system held the largest market share and the Indian market of Ablation Devices was the fastest growing market in the Asia-Pacific region.
Ablation Devices Key Market Players & Competitive Insights
Leading market players are investing heavily in research and development in order to expand their product lines, which will help the market of Ablation Devices, grow even more. Market participants are also undertaking a variety of strategic activities to expand their global footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, Ablation Devices industry must offer cost-effective items.
Manufacturing locally to minimize operational costs is one of the key business tactics used by manufacturers in the global Ablation Devices industry to benefit clients and increase the market sector. In recent years, the Ablation Devices industry has offered some of the most significant advantages to medicine. Major players in the ablation system market, including Boston Scientific Corporation, Smith & Nephew PLC, St. Jude Medical, Inc., Medtronic PLC, Johnson and Johnson, BTG plc, AtriCure, Inc., Olympus Corporation, Conmed Corporation, AngioDynamics, Inc., Accuray Incorporated, C.R. Bard, Inc., Varian Medical Systems, Inc., Elekta AB, Misonix, Inc., Hologic, Inc., Stryker Corporation, EDAP TMS S.A., Japan Lifeline Co., Ltd., Halyard Health, Inc., Merit Medical Systems, Inc., Integra Lifesciences Holdings Corporation, Abbott Laboratories, and Terumo Corporation, are attempting to increase market demand by investing in research and development Technologys.
A medical technology firm called Medtronic Plc (Medtronic), originally known as Medtronic Inc., creates, develops, produces, and sells a variety of medical products. It provides products for the treatment of conditions such heart valve issues, heart failure, aortic, peripheral vascular, venous renal, and neurological problems, as well as spine and musculoskeletal issues, ear, nose, and throat conditions. A definitive agreement was signed in January 2022 by Medtronic plc and Affera, Inc.
An organization called Quantum Surgical sells surgical robots that are designed to be intelligent instruments for minimally invasive procedures. The company's robotics aids in enhanced percutaneous ablation therapy for the treatment of liver cancer, allowing medical professionals to save their patients' lives and perform safer interventional oncology operations while also curing them. The Epione robot, which can plan, target, deliver, and confirm tumor ablation for cancer treatment, was given 510(k) clearance by the US Food and Drug Administration in March 2022.
Key Companies in the market of Ablation Devices include
- Boston Scientific Corporation
- Smith & Nephew PLC
- Jude Medical Inc.
- Medtronic PLC
- Johnson and Johnson
- BTG plc
- AtriCure, Inc.
- Olympus Corporation
- Conmed Corporation
- AngioDynamics, Inc.
- Accuray Incorporated
- R. Bard, Inc.
- Varian Medical Systems Inc.
- Elekta AB
- Misonix, Inc.
- Hologic Inc.
- Stryker Corporation
- EDAP TMS S.A.
- Japan Lifeline Co., Ltd.
- Halyard Health, Inc.
- Merit Medical Systems, Inc.
- Integra Lifesciences Holdings Corporation
- Abbott Laboratories
- Terumo Corporation
Ablation Devices Industry Developments
October 2022Â For the treatment of Barrett's esophagus, the C2 CryoBalloon Ablation System was made available in Canada.
Ablation Devices Market Segmentation
Ablation System Technology Outlook
-
Thermal Ablation
-
Non-Thermal Ablation
Ablation Devices Application Outlook
-
Cancer
-
Cardiovascular
-
Ophthalmology
-
Gynecology
-
Urology
-
Orthopedics
-
Others
Ablation Devices Function Outlook
-
Automated/Robotic
-
Conventional
Ablation Devices Procedure Outlook
-
Aesthetics-Skin Rejuvenation and Tightening
-
Aesthetics-Body Sculpting, Fat Reduction, and The Reduction in The Appearance of Cellulite
-
Benign Prostatic Hyperplasia
-
Transurethral Needle Ablation
-
Laser and Other Energy-Based Therapies/Holmium Laser Ablation/Enucleation Of The Prostate
-
Stress Urinary Incontinence
-
Menorrhagia/Endometrial Ablation
-
Uterine Fibroids
-
Spinal Decompression and Denervation
-
Varicose Veins
-
Atrial Fibrillation
-
Tumor Ablation
-
Others
Ablation Devices Regional Outlook
-
North America
-
Europe
-
Germany
-
France
-
UK
-
Italy
-
Spain
-
Rest of Europe
-
Asia-Pacific
-
China
-
Japan
-
India
-
Australia
-
South Korea
-
Australia
-
Rest of Asia-Pacific
-
Rest of the World
-
Middle East
-
Africa
-
Latin America
| Report Attribute/Metric |
Details |
| Market Size 2022 |
USD 8.2 Billion |
| Market Size 2023 |
USD 9.0 Billion |
| Market Size 2032 |
USD 18.6 Billion |
| Compound Annual Growth Rate (CAGR) |
9.50% (2023-2032) |
| Base Year |
2022 |
| Market Forecast Period |
2023-2032 |
| Historical Data |
2018- 2022 |
| Market Forecast Units |
Value (USD Billion) |
| Report Coverage |
Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends |
| Segments Covered |
Technology, Application, Function, Procedure, and Region |
| Geographies Covered |
North America, Europe, Asia Pacific, and the Rest of the World |
| Countries Covered |
The U.S., Canada, German, France, U.K, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil |
| Key Companies Profiled |
Boston Scientific Corporation, Smith & Nephew PLC, St. Jude Medical, Inc., Medtronic PLC, Johnson and Johnson, BTG plc, AtriCure, Inc., Olympus Corporation, Conmed Corporation, AngioDynamics, Inc., Accuray Incorporated, C.R. Bard, Inc., Varian Medical Systems, Inc., Elekta AB, Misonix, Inc., Hologic, Inc., Stryker Corporation, EDAP TMS S.A., Japan Lifeline Co., Ltd., Halyard Health, Inc., Merit Medical Systems, Inc., Integra Lifesciences Holdings Corporation, Abbott Laboratories, and Terumo Corporation |
| Key Market Opportunities |
Innovation in technologically advanced ablation devices |
| Key Market Dynamics |
Increasing demand for thyroid ablation procedures as well as devices owing to the rising prevalence of thyroid cancer and thyroid nodules and the growing preference for minimally invasive surgeries |
Ablation Devices Market Highlights:
Frequently Asked Questions (FAQ) :
The Ablation Devices Market size was valued at USD 8.2 Billion in 2022.
The global market is projected to grow at a CAGR of 9.50% during the forecast period, 2023-2032.
North America had the largest share in the global market
The key players in the market are Boston Scientific Corporation, Smith & Nephew PLC, St. Jude Medical, Inc., Medtronic PLC, Johnson and Johnson, BTG plc, AtriCure, Inc., Olympus Corporation, Conmed Corporation, AngioDynamics, Inc., Accuray Incorporated, C.R. Bard, Inc., Varian Medical Systems, Inc., Elekta AB, Misonix, Inc., Hologic, Inc., Stryker Corporation, EDAP TMS S.A., Japan Lifeline Co., Ltd., Halyard Health, Inc., Merit Medical Systems, Inc., Integra Lifesciences Holdings Corporation, Abbott Laboratories, and Terumo Corporation
The Thermal Ablation Technology dominated the market in 2022.
The Cancer Application had the largest share in the global market.
